These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 1828347

  • 1. Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.
    Deliganis AV, Pierce PA, Peroutka SJ.
    Biochem Pharmacol; 1991 Jun 01; 41(11):1739-44. PubMed ID: 1828347
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A, Sebben M, Bockaert J.
    Mol Pharmacol; 1988 Feb 01; 33(2):178-86. PubMed ID: 2828913
    [Abstract] [Full Text] [Related]

  • 3. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L, Teitler M, Fletcher PW, Ismaiel AM, Glennon RA.
    Brain Res; 1990 Nov 05; 532(1-2):191-6. PubMed ID: 2282513
    [Abstract] [Full Text] [Related]

  • 4. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
    Pierce PA, Peroutka SJ.
    J Pharmacol Exp Ther; 1988 Dec 05; 247(3):918-25. PubMed ID: 3204523
    [Abstract] [Full Text] [Related]

  • 5. Antagonism of 5-hydroxytryptamine1A (5-HT1A) receptor-mediated modulation of adenylate cyclase activity by pindolol and propranolol isomers.
    Oksenberg D, Peroutka SJ.
    Biochem Pharmacol; 1988 Sep 15; 37(18):3429-33. PubMed ID: 2971358
    [Abstract] [Full Text] [Related]

  • 6. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar 15; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E, Budziszewska B, Warchoł-Kania A, Błaszczyńska E.
    Pharmacol Biochem Behav; 1989 Jun 15; 33(2):329-34. PubMed ID: 2530590
    [Abstract] [Full Text] [Related]

  • 14. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ, Rivet JM, Canton H, Lejeune F, Bervoets K, Brocco M, Gobert A, Lefebvre de Ladonchamps B, Le Marouille-Girardon S, Verriele L.
    J Pharmacol Exp Ther; 1992 Aug 15; 262(2):451-63. PubMed ID: 1323650
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J.
    Mol Pharmacol; 1988 Dec 15; 34(6):880-7. PubMed ID: 2849052
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L, Giromella A, Marazziti D, Borsini F, Naccarato AG, Giannaccini G, Lucacchini A, Cassano GB, Mazzoni MR.
    Brain Res; 1999 Jan 16; 816(1):165-74. PubMed ID: 9878719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.